Journal Information
Original Article
Full text access
Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis
N.P.M. Rubinia, L.F.C. Ensinab, E.M.K. Silvac, F. Sanod, D. Solée,
Corresponding author
dirceu.sole@unifesp.br
Corresponding author at: Rua dos Otonis 725, Vila Clementino, São Paulo 04025-002, SP, Brazil.
Corresponding author at: Rua dos Otonis 725, Vila Clementino, São Paulo 04025-002, SP, Brazil.
a School of Medicine and Surgery, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil
b Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Escola Paulista de Medicina, Federal University of São Paulo (EPM-UNIFESP), São Paulo, Brazil
c Division of Emergency and Evidence Based Medicine, EPM-UNIFESP and Researcher of Cochrane Center of Brazil, São Paulo, Brazil
d Nipo-Brazilian Hospital, São Paulo, Brazil
e Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, EPM-UNIFESP, São Paulo, Brazil
Article
This article is available in English
Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis
N.P.M. Rubini, L.F.C. Ensina, E.M.K. Silva, F. Sano, D. Solé
10.1016/j.aller.2019.05.003Allergol Immunopathol (Madr). 2019;47:515-22